Learn how the FDA's 180-day exclusivity works for generic drug applicants, including Paragraph IV certifications, forfeiture risks, and upcoming regulatory changes.
Dec, 1 2025
Dec, 4 2025
Jan, 8 2026
Mar, 27 2026
Feb, 13 2026